High-mobility group box 1 protein promotes development of microvascular thrombosis in rats - PubMed (original) (raw)
Comparative Study
High-mobility group box 1 protein promotes development of microvascular thrombosis in rats
T Ito et al. J Thromb Haemost. 2007 Jan.
Free article
Abstract
Background: Sepsis is a life-threatening disorder resulting from systemic inflammatory and coagulatory responses to infection. High-mobility group box 1 protein (HMGB1), an abundant intranuclear protein, was recently identified as a potent lethal mediator of sepsis. However, the precise mechanisms by which HMGB1 exerts its lethal effects in sepsis have yet to be confirmed. We recently reported that plasma HMGB1 levels correlated with disseminated intravascular coagulation (DIC) score, indicating that HMGB1 might play an important role in the pathogenesis of DIC.
Objectives: To investigate the mechanisms responsible for the lethal effects of HMGB1, and more specifically, to explore the effects of HMGB1 on the coagulation system.
Methods: Rats were exposed to thrombin with or without HMGB1, and a survival analysis, pathologic analyses and blood tests were conducted. The effects of HMGB1 on the coagulation cascade, anticoagulant pathways and surface expression of procoagulant or anticoagulant molecules were examined in vitro.
Results: Compared to thrombin alone, combined administration of thrombin and HMGB1 resulted in excessive fibrin deposition in glomeruli, prolonged plasma clotting times, and increased mortality. In vitro, HMGB1 did not affect clotting times, but inhibited the anticoagulant protein C pathway mediated by the thrombin-thrombomodulin complex, and stimulated tissue factor expression on monocytes.
Conclusions: These findings demonstrate the procoagulant role of HMGB1 in vivo and in vitro. During sepsis, massive accumulation of HMGB1 in the systemic circulation would promote the development of DIC.
Similar articles
- Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
Esmon CT. Esmon CT. Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):343-59. doi: 10.1053/beha.1999.0029. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10856974 Review. - Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.
Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H, Nawa Y, Meng X, Shrestha B, Hashiguchi T, Maruyama I. Ito T, et al. Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1825-30. doi: 10.1161/ATVBAHA.107.150631. Epub 2008 Jul 3. Arterioscler Thromb Vasc Biol. 2008. PMID: 18599803 - Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG, von dem Borne PA, Bouma BN, Meijers JC. Elisen MG, et al. Blood. 1998 Mar 1;91(5):1542-7. Blood. 1998. PMID: 9473218 - High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
Eskici ZM, Açıkgöz Ş, Pişkin N, Mungan G, Can M, Güven B, Köktürk F. Eskici ZM, et al. Acta Biochim Pol. 2012;59(4):561-6. Epub 2012 Oct 23. Acta Biochim Pol. 2012. PMID: 23094260 - Coagulopathy of Acute Sepsis.
Semeraro N, Ammollo CT, Semeraro F, Colucci M. Semeraro N, et al. Semin Thromb Hemost. 2015 Sep;41(6):650-8. doi: 10.1055/s-0035-1556730. Epub 2015 Aug 25. Semin Thromb Hemost. 2015. PMID: 26305237 Review.
Cited by
- Revealing the extracellular function of HMGB1 N-terminal region acetylation assisted by a protein semi-synthesis approach.
Wei T, Liu J, Li C, Tan Y, Wei R, Wang J, Wu H, Li Q, Liu H, Tang Y, Li X. Wei T, et al. Chem Sci. 2023 Sep 7;14(37):10297-10307. doi: 10.1039/d3sc01109g. eCollection 2023 Sep 27. Chem Sci. 2023. PMID: 37772093 Free PMC article. - Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview.
Unar A, Bertolino L, Patauner F, Gallo R, Durante-Mangoni E. Unar A, et al. Cells. 2023 Aug 22;12(17):2120. doi: 10.3390/cells12172120. Cells. 2023. PMID: 37681852 Free PMC article. Review. - Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury.
Shimono K, Ito T, Kamikokuryo C, Niiyama S, Yamada S, Onishi H, Yoshihara H, Maruyama I, Kakihana Y. Shimono K, et al. Thromb J. 2023 Sep 6;21(1):91. doi: 10.1186/s12959-023-00536-w. Thromb J. 2023. PMID: 37674235 Free PMC article. - A two-decade journey in identifying high mobility group box 1 (HMGB1) and procathepsin L (pCTS-L) as potential therapeutic targets for sepsis.
Li J, Zhu CS, He L, Qiang X, Chen W, Wang H. Li J, et al. Expert Opin Ther Targets. 2023 Jul-Dec;27(7):575-591. doi: 10.1080/14728222.2023.2239495. Epub 2023 Jul 25. Expert Opin Ther Targets. 2023. PMID: 37477229 Free PMC article. Review. - Biological Effects of New Titanium Surface Coatings Based on Ionic Liquids and HMGB1: A Cellular and Molecular Characterization in Lewis Rats.
Arteaga A, Biguetti CC, Lakkasetter Chandrashekar B, Mora J, Qureshi A, Rodrigues DC. Arteaga A, et al. ACS Biomater Sci Eng. 2023 Aug 14;9(8):4709-4719. doi: 10.1021/acsbiomaterials.3c00367. Epub 2023 Jul 7. ACS Biomater Sci Eng. 2023. PMID: 37418317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical